Expert panel to soon weigh plan to use generics for prescription drugs

An expert committee is set to discuss the feasibility of allowing generic substitutions for prescription drugs in India. The proposal has sparked a disagreement between the Indian Pharmaceutical Alliance (IPA) and the All India Drug Action Network (AIDAN). The IPA opposes the idea, arguing that it would lead to a surge of demand from trade channels, such as general pharmacy stores, which would not benefit patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NnEyFvX
via IFTTT